Peptide therapeutics are molecules composed of small chains of amino acids that can be designed to selectively target and modulate specific biological pathways in the body.
Advantages:
High specificity: Peptide therapeutics can be designed to specifically target and interact with receptors or enzymes involved in metabolic pathways, which can increase their efficacy and reduce off-target effects.
Improved safety profile: Peptide therapeutics are typically less toxic than small molecule drugs, which can reduce the risk of adverse events and improve patient safety.
Enhanced pharmacokinetics: Peptide Therapeutics in Metabolic Disorders can be modified to improve their stability and half-life in the body, which can increase their effectiveness and reduce the frequency of dosing.
Low immunogenicity: Peptide therapeutics are generally well-tolerated by the immune system, which can reduce the risk of allergic or immune reactions.
Read More:
